Cargando…
A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
Background: Cardiovascular disease remains the primary cause of death among Australians, despite dramatic improvements in overall cardiovascular health since the 1980s. Treating cardiovascular disease continues to place a significant economic strain on the Australian health care system, with direct...
Autores principales: | McCreanor, Victoria, Graves, Nicholas, Barnett, Adrian G, Parsonage, Will, Merlo, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039943/ https://www.ncbi.nlm.nih.gov/pubmed/30026922 http://dx.doi.org/10.12688/f1000research.13616.2 |
Ejemplares similares
-
Pharmaceutical use and costs in patients with coronary artery disease, using Australian observational data
por: McCreanor, Victoria, et al.
Publicado: (2019) -
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
por: McCreanor, Victoria, et al.
Publicado: (2021) -
Reducing waste in collection of quality-of-life data through better reporting: a case study
por: McCreanor, Victoria, et al.
Publicado: (2022) -
Quality of life measured by EQ-5D at different treatment time points for coronary artery disease: protocol for a systematic review and meta-analysis
por: Lum, Elaine, et al.
Publicado: (2020) -
Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
por: Senanayake, Sameera, et al.
Publicado: (2023)